HBM Holdings-B (02142) spent HKD 322,300 to repurchase 110,000 shares on January 21.
Boehringer Ingelheim-B (02142) announced that the company invested HKD 322,300 on January 21, 2025.
HBM HOLDINGS-B (02142) announced that on January 21, 2025, the company repurchased 110,000 shares at a price of HK$2.93 per share, totaling HK$322,300.
On the same day, 26,000 ordinary shares were issued to meet the share incentive plan adopted and approved by the company shareholders on November 23, 2020.
Related Articles
Xingzheng Securities: September will be a crucial decisive window for technology, and high-quality tech assets are still expected to be the core driving force for market recovery.
Jiangsu Hengrui Pharmaceuticals (01276) experiences a shift in growth structure: acceleration of the second curve and global value release.
Zhejiang Shibao (01057) released its interim results, with a net profit attributable to shareholders of 104 million yuan, an increase of 11.48% year-on-year.
Xingzheng Securities: September will be a crucial decisive window for technology, and high-quality tech assets are still expected to be the core driving force for market recovery.
Jiangsu Hengrui Pharmaceuticals (01276) experiences a shift in growth structure: acceleration of the second curve and global value release.
Zhejiang Shibao (01057) released its interim results, with a net profit attributable to shareholders of 104 million yuan, an increase of 11.48% year-on-year.
RECOMMEND
